Beppino C. Giovanella, Ph.D.
Zhisong Cao, Ph.D.
Associate Laboratory Director, Chief Chemist
Deputy Director/Clinical Operations Officer
Constantine Markides, Ph.D.
Xing (Lucy) Liu, Ph.D.
Research Scientist, Analytical Chemistry
Anthony (Tony) Kozielski
Section Supervisor, Chemotherapy
Yang Wang, Ph.D.
Research Scientist, Synthetic Chemistry
Tissue Culture Supervisor
Edward (Eddie) Petry, Jr.
Vivarium Section Supervisor
CHRISTUS Stehlin Foundation for Cancer Research will join CHRISTUS St. Catherine and CHRISTUS St. John in a new partnership with Houston Methodist.
There are currently 13.7 million cancer survivors in the United States and the number is expected to rise by 31 percent to 18 million by 2022, according to a new report. >> Click article title for more.
“I have been constantly impressed not only with the CHRISTUS Stehlin Foundation’s rich legacy of transformative research, but also the tenacious commitment of foundation staff to the vision of Dr. Stehlin. A connection between this vision and the mission of our sponsoring congregations was immediately clear, as both seek not only to treat illness, but also honor the dignity inherent in every person.”
Tom Royer, M.D.,
CEO Emeritus, CHRISTUS Health, 2011